Market Place
Sourcing Support
Biomic Sciences Receives FDA Warning Letters
28 May 2024 //
FDA
Biomica Bmc128 Microbiome Positive: Ph1 Refractory Solid Tumors Update
23 May 2024 //
PR NEWSWIRE
Biomica CEO Set to Engage in Discussion at European Microbiome Movement Summit
23 Jan 2024 //
PR NEWSWIRE
Biomica Successfully Completes Phase I Trial Enrollment for Immuno-Oncology Drug
17 Jan 2024 //
PR NEWSWIRE
Biomica Opens Site to Advance Its Immuno-Oncology Drug Trials at Davidoff Center
15 Aug 2023 //
PR NEWSWIRE
Biomica Announces Closing of $20 Million Financing Round led by Shanghai
27 Apr 2023 //
PR NEWSWIRE
Biomica VP R&D to Present at the Pharmabiotics 2023 Conference on March 21, 2023
15 Mar 2023 //
PR NEWSWIRE
Biomica CEO to Participate in Panel Discussion at Annual Microbiome Movement
24 Jan 2023 //
PR NEWSWIRE
Biomica CEO to Participate in an Industry Panel Discussion at USA Summit
14 Nov 2022 //
PRNEWSWIRE
Biomica Announces 1st Patient Dosed in PI Study of its Microbiome-Based IO Drug
26 Jul 2022 //
PRNEWSWIRE
Biomica to Present at the Microbiome Connect Europe 2022
05 Jul 2022 //
PRNEWSWIRE
Biomica to Present at the 7th Microbiome Movement Drug Development Summit
15 Jun 2022 //
PRNEWSWIRE
Biomica to Present at the ASCO 2022 Annual Meeting
23 May 2022 //
PRNEWSWIRE
Biomica Announces Agreement with Sheba Medical Center
13 Apr 2022 //
PRNEWSWIRE
Biomica Announces Clearance for First-in-Human Phase I Study of BMC-128
11 Jan 2022 //
PRNEWSWIRE
Biomica & Rambam Health Care Campus Sign Agreement for Clinical Trial
27 Oct 2021 //
PRNEWSWIRE
Biomica Announces Positive Pre-Clinical Results, Demonstrating Efficacy BMC128
13 Apr 2021 //
PRNESWIRE
Biomica Announces Positive Pre-Clinical Results, Efficacy of BMC128
12 Apr 2021 //
PRNESWIRE
Biomica Announces Initiation of Large-Scale Production of (LBP) Candidate
13 Oct 2020 //
PRNEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.